INDRAMEDCO
Indramedco
Live Price
₹318.30
+4.70+1.50%
Conviction Scorecard
AI Momentum
18%Technical Rating
42%Analyst Sentiment
85%Market News & Buzz
📰
Recent news and updates for INDRAMEDCO will appear here soon.
Stockmo Analyst Rationale
AI Generated Insight
"Caution advised for INDRAMEDCO investors. AI signals correlate with a sustained bearish trend. Technical indicators suggest further consolidation within the healthcare sector before a reliable long-term bottom is established."
Verified by Stockmo Intelligence Grid
Supporting Evidence
Citing cross-referenced internal documents and market technicals
About Indramedco
Indraprastha Medical Corporation Limited provides hospital services in India. The company offers services primarily in the areas of genomic medicine, internal medicine, elder care, anesthesiology, bariatric and metabolic surgery, bone marrow transplant, dental and cosmetic clinic, dermatology, dietetics and clinical nutrition, vascular and endovascular surgery, endocrinology, ENT, fetal medicine, general and laparoscopic surgery, gynecology and obstetrics, hyperbaric oxygen therapy, IVF, neonatology, nephrology, nuclear medicine, ophthalmology, pediatric sciences, urology, and plastic and cosmetic surgery, as well as pediatric urology and surgery, physiotherapy and rehabilitation, psychiatry and clinical psychology, radiology and radio diagnosis, respiratory, rheumatology, spine surgery, urology and andrology, cardiology, oncology, emergency care, gastroenterology, neurology/neurosurgery, critical care, orthopedics, robotic surgery, and organ transplant, as well as laboratory services, interventional medicine, preventive medicine, and sleep medicine. Indraprastha Medical Corporation Limited was founded in 1983 and is based in New Delhi, India.
Frequently asked questions
As of the latest market session, Indramedco (INDRAMEDCO) is trading at ₹318.3, representing a move of 1.50% from the previous close.
Indramedco is listed and traded under the ticker symbol INDRAMEDCO on the National Stock Exchange of India (NSE) and Bombay Stock Exchange (BSE).
Today, Indramedco's stock price moved by 1.50%. Long-term growth trends depend on company financials, technical moving averages, and sector momentum in the Healthcare industry.
Our proprietary AI Momentum engine calculates a 18% bullish probability for INDRAMEDCO stock over the next 3-5 days. View the live interactive chart on Stockmo to see dynamic technical forecasting.
Over the past 52 weeks, Indramedco shares reached a high of ₹640.85 and hit a low of ₹293.65.
INDRAMEDCO exhibits standard volatility for a Healthcare stock, with an average daily trading volume of 90,197 shares. Detailed technical beta indicators are available on the Stockmo charting engine.
Indramedco has a market capitalization of ₹2917.95 Cr, designating its size class inside the Healthcare sector.
Indramedco has a current dividend yield of 128.00%. Companies may adjust payout ratios depending on quarterly earnings growth and reinvestment opportunities.
Indramedco's trailing Price-to-Earnings (P/E) ratio is 15.52. This indicates how much investors are willing to pay for every rupee of the company's annual net earnings.
You can purchase Indramedco (INDRAMEDCO) shares through any SEBI-registered stockbroker (such as Kite/Zerodha, Groww, or Angel One) by funding your trading account and executing a buy order on the NSE or BSE.
Indramedco's financial health, solvency, growth, and quality metrics are tracked using our proprietary Multibagger V2 score. You can explore INDRAMEDCO's detailed 5-tier financial scorecard and compare it with market competitors on the Stockmo Multibagger Screener page.
Institutional order blocks and pristine support/resistance triggers for INDRAMEDCO are monitored in real-time. View live technical entry levels, stop loss bounds, and target prices on our interactive Supply & Demand Trading Engine or scan entire market segments using the Basket Scanner.
Indramedco operates inside the Healthcare sector. You can analyze sector-wide trends, relative strengths, and locate top emerging leaders in this space using our Sector Analysis Hub.